Preclinical trials of epigenetic reprogramming have shown no apparent negative side effects to date, allowing advancement to non-human primate testing, with the goal of human trials for vision restoration within 2 years.
forecastpending
Speaker
David SinclairEvidence Quote
“we're now testing it uh in non-human primates just to see if it's safe my gosh and if all goes well in the next 2 years we'll hopefully cure blindness in people”
Created: 8/12/2026, 6:35:40 PM
Your notes
Loading notes...